Local view for "http://purl.org/linkedpolitics/eu/plenary/2008-04-10-Speech-4-207"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20080410.30.4-207"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:translated text |
".
Are EU measures in the urgent fight against cancer more effective than corresponding measures in the context of existing international organisations with broad expertise, such as the WHO? Do the EU institutions have more extensive competence than the Member States in methods of combating cancer? Our answer to these questions is ‘no’.
The Resolution calls, among other things, for an interinstitutional EU Cancer Task Force, EU-sponsored information and education campaigns on cancer, an advisory committee on cancer prevention to be set up by the Commission, legislative action by the EU to encourage and support initiatives concerned with the lack of sun protection, action by the Commission to create smoke-free environments, nationwide provision by the Member States for multidisciplinary oncology teams and recognition of oncology as a medical speciality.
The idea behind these views and demands is certainly laudable. The fundamental question, however, is: what value added is there in having the EU regulate all these things? Where is trust in the Member States? What happened to the subsidiarity principle? Does EU regulatory action really benefit those who are in need of qualitative legislation and well-considered measures, namely cancer patients? Where is the realisation that cancer is a global problem, which should be approached at a global level?
On the basis of the above arguments, Junilistan voted against the report in question in the final vote."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples